The authors reported that the FAM167A/desmoglein-1 (DSG1) axis regulated the noncanonical NF-κB pathway and controlled BCR-ABL-independent resistance in CML cells derived from CML patients [117]. This evidence concerns the gene NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive.